Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study

Takayuki Hamano, Fumihiko Koiwa, Yoshitaka Isaka, Keitaro Yokoyama, Masafumi Fukagawa, Yosuke Inagaki, Yukihisa S. Watanabe, Daisuke Honda, Tadao Akizawa

Open source

DOI: 10.1159/000541493
Published: 2024-09-19
Container: American Journal of Nephrology
Publisher: S. Karger AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000541493,
  title = {Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study},
  author = {Takayuki Hamano and Fumihiko Koiwa and Yoshitaka Isaka and Keitaro Yokoyama and Masafumi Fukagawa and Yosuke Inagaki and Yukihisa S. Watanabe and Daisuke Honda and Tadao Akizawa},
  year = {2024},
  journal = {American Journal of Nephrology},
  doi = {10.1159/000541493},
  url = {https://doi.org/10.1159/000541493}
}

RIS

TY  - JOUR
TI  - Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study
AU  - Takayuki Hamano
AU  - Fumihiko Koiwa
AU  - Yoshitaka Isaka
AU  - Keitaro Yokoyama
AU  - Masafumi Fukagawa
AU  - Yosuke Inagaki
AU  - Yukihisa S. Watanabe
AU  - Daisuke Honda
AU  - Tadao Akizawa
PY  - 2024
JO  - American Journal of Nephrology
DO  - 10.1159/000541493
UR  - https://doi.org/10.1159/000541493
ER  -

APA

Hamano, T., Koiwa, F., Isaka, Y., Yokoyama, K., Fukagawa, M., Inagaki, Y., Watanabe, Y. S., Honda, D., & Akizawa, T. (2024). Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study. American Journal of Nephrology. https://doi.org/10.1159/000541493

Source records

crossref · retrieved 2026-09-27T12:40:21.059Z